Delivery Order 36C25022D0022-36C25023N0239
- Not listed
- This federal contract award to Biofire Diagnostics LLC, a foreign-owned for-profit biotechnology company, was issued by the Department of Veterans Affairs' Veterans Integrated Service Network 10. The $87,232.50 firm-fixed-price delivery order contract is for the provision of specialized diagnostic testing panels, reagents, and associated services. The contract has an ultimate completion date of January 16, 2024 and was awarded on November 30, 2021. Biofire Diagnostics is an experienced federal...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, a $126,652.50 firm-fixed-price purchase order for BioFire RP2.1 panel reagents. The contract has a completion date of February 15, 2022 and was awarded on December 3, 2020. Biofire Diagnostics is a leader in syndromic infectious disease testing and has received numerous federal contracts from agencies such as the VA, Defense Health Agency,...
- This federal contract award to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, is for the provision of reagents and test kits. The contract is a delivery order against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The $1,395,556.66 contract is with the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and its various Veterans Integrated Service Networks (VISNs), and is...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit organization that specializes in syndromic infectious disease testing. The $125,500.00 firm-fixed-price purchase order does not have a set-aside designation. Biofire Diagnostics LLC has received numerous federal contracts as a prime contractor to provide a variety of goods and services related to infectious disease...
- This federal contract award to Biofire Diagnostics LLC, a foreign-owned for-profit organization, is for the delivery of reagents for laboratory testing. The contract has a potential value of $438,741.54 and is a delivery order under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. The contract is with the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service...
- This federal contract award to Biofire Diagnostics LLC, a foreign-owned for-profit organization, is for the provision of BIOFIRE RP2.1 REAGENTS KITS to the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 10. The award, valued at $386,662.08, is a firm fixed-price purchase order with a completion date of June 30, 2022. The contract is not set-aside and is associated with the Biofire Diagnostics LLC's General Services Administration...
- This federal contract award to Biofire Diagnostics LLC, a foreign-owned for-profit organization, is for molecular pathogen detection services. The $654,849 Firm Fixed Price contract was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 8 against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract has no set-aside designation. Biofire Diagnostics has...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide COVID-19 testing reagents. The $223,560 firm fixed-price purchase order has a completion date of September 30, 2021. Biofire Diagnostics LLC has received numerous federal contracts to supply infectious disease testing products and services, including molecular diagnostic testing, reagents, and maintenance...
- The U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 10 awarded a Firm Fixed Price Delivery Order contract to Biofire Diagnostics LLC, a foreign-owned for-profit organization, to provide Biofire reagents through December 31, 2026. The initial delivery order value is $550,736.25. Biofire Diagnostics LLC is a leading provider of syndromic infectious disease testing products and services to federal agencies, including the VA, Defense Health Agency, Indian Health...
- This federal contract award to Biofire Diagnostics LLC, a foreign-owned for-profit organization, is for the provision of BIOFIRE REAGENTS AND TEST KITS to the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) across various Veterans Integrated Service Networks (VISNs). The contract is a Blanket Purchase Agreement (BPA) Call against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract...
- 36C25022D0022Indefinite Delivery Contract
- 36C25022D0022-36C25023N0239Delivery Order
This federal contract award to Biofire Diagnostics LLC, a foreign-owned for-profit organization, was issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 10 for the delivery of Biofire reagents. The $243,869.18 delivery order contract has a firm fixed price and a completion date of December 31, 2023. Biofire Diagnostics LLC has received numerous awards from various federal agencies, including the VA, Defense Health Agency, and Indian Health Service, to provide infectious disease testing products and services. These awards leverage Biofire's General Services Administration Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($307k) | 4/18/24 | |
| P00001 | Other Administrative Action | $0 | 5/11/23 | |
| Not listed | Not listed | $550.7k | 1/3/23 |